<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Epstein-Barr virus (EBV)-carrying Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>) lines which maintain the phenotypic characteristics of the in vivo <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells are more sensitive to natural (NK), interferon-activated (IAK) and IL-2-activated (LAK) cytotoxicity than EBV-immortalized lymphoblastoid cell lines (LCL) of <z:mpath ids='MPATH_458'>normal</z:mpath> B-cell origin </plain></SENT>
<SENT sid="1" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> cells carry chromosomal translocations which lead to deregulated expression of the c-myc oncogene </plain></SENT>
<SENT sid="2" pm="."><plain>LCLs transfected with constitutively active c-myc alleles display changes in growth properties and surface phenotype </plain></SENT>
<SENT sid="3" pm="."><plain>In this study, we have examined the effect of c-myc deregulation on the sensitivity of LCLs to NK, IAK and LAK effectors </plain></SENT>
<SENT sid="4" pm="."><plain>C-myc-transfected LCLs showed an increased sensitivity to lysis which correlated with the level of c-myc expression </plain></SENT>
<SENT sid="5" pm="."><plain>Expression of HLA class I and sensitivity to allospecific and EBV-specific cytotoxic T-lymphocytes (CTL) remained unchanged </plain></SENT>
<SENT sid="6" pm="."><plain>Transfection of a constitutively active v-H-ras gene, which also induces changes in growth properties and cell-surface phenotype, did not alter the sensitivity of LCLs to NK or LAK cytotoxicity </plain></SENT>
</text></document>